It has been reported that ITGA2 is expressed more significantly in glioblastoma compared with normal glial cells, and targeting ITGA2 through monoclonal antibody could impede the migration of glioblastoma cells, but not their proliferation (42). Here, ITGA2 is linked to glioblastoma.